Brachyury, a driver of tumor invasiveness and resistance to multiple therapies, is a novel immunotherapy target

Podobne zapisy

• The role of oncogenic MUC1-C in brachyury-induced immunotherapy resistance
  od: David, Justin, i wsp.
  Wydane: (2014)
• Upregulation of oncogenic MUC1 by the EMT transcription factor brachyury mediates immunotherapy-resistance in tumor cells
  od: David, Justin M, i wsp.
  Wydane: (2015)
• Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody
  od: Hamilton, Duane H., i wsp.
  Wydane: (2014)
• Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of Brachyury and other drivers of the mesenchymal-like phenotype of carcinomas
  od: Hamilton, Duane H., i wsp.
  Wydane: (2012)
• The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells
  od: Fernando, Romaine I., i wsp.
  Wydane: (2010)